Phenyl-substituted piperidine compounds and their preparation and use in treating calcium overload in brain cells of mammals
CA 1323367 C · Owner: Novo Nordisk A/S · Inventors: Drejer, Jýrgen; Jakobsen, Palle
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel piperidine compounds having the formula wherein, R3 is 3,4-methylenedioxyphenyl aryl or heteroaryl which, are optionally substituted with one or more C1-6-alkyl C1-6-alkoxy, C3-8-cycloalkyl, C3-5-alkylene or aralkoxy, R1 is straight or branched C1-8-alkyl C4-8-alkoxy-C4-8-al-, kyl, C4-7-cycloalkyl aryloxy-C3-8-alkyl, C4-8-alkenyl, or, C4-8-cycloalkylalkyl or R1 may also be hydrogen or C1-3-, alkyl when R3 is aryl, which is substituted with two or more of C1-6- alkyl, C1-6-alkoxy, C3-8-cycloalkyl aralkoxy, or with C3-5- alkylene. X is hydrogen or halogen and wherein, Y is O or S, and a salt thereof with a pharmaceutically acceptable acid. The novel compounds are useful in the treatment …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted October 19, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 19, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.